BMS-354825;Dasatinib NEW

Factory Provide Anti-Cancer BMS-354825 CAS 302962-49-8 Dasatinib Powder

Introduction

Product Name : Dasatinib

Other name:BMS354825;DASATINIB (BMS 354825);CS-1968;N-(2-chloro-6-Methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-Methyl-4-pyriMidinyl]aMino]-1,3-thiazole-5-carboxaMide;

CAS No.:302962-49-8

MF:C22H26ClN7O2S

Purity :99%

MW:488.01

Melting Point :275-286°C

Density :1.408±0.06 g/cm3(Predicted)

Appearance: white to off white powder

Storage :Sealed in dry,Sealed in dry,Room Temperature

Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body. Dasatinib, previously known as BMS-354825, Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Function and Application 

Dasatinib is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective.
Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitorapproved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia.